DR. MARAYS VELIZ MD NPI 1023213089

NPI Information

  • NPI: 1023213089
  • Provider Name: DR. MARAYS VELIZ, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 601 E DIXIE AVE STE 1001
    LEESBURG, FL
    ZIP 34748
  • Phone: (352) 787-9448

Map and Directions

Get Directions

NPI Details

DR. Marays Veliz, MD is a medical oncology internal medicine in Leesburg, FL with 23 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Marays Veliz, MD NPI is 1023213089. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

601 E DIXIE AVE STE 1001
LEESBURG, FL
ZIP 34748-309
Phone: (352) 787-9448
Fax: (352) 787-3250

The NPI 1023213089 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron level (HCPCS:83540)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Folic acid level, serum (HCPCS:82746)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Magnesium level (HCPCS:83735)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Iron binding capacity (HCPCS:83550)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Blood test, clotting time (HCPCS:85610)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Automated urinalysis test (HCPCS:81003)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Red blood count, manual test (HCPCS:85044)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Erythropoietin (protein) level (HCPCS:82668)

The enumeration date for this NPI number is 6/19/2007 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME106712FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME106712FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1002251600MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.